Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 2,856.40
+12.00 (0.42%)
Jan 7, 2026, 12:30 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 355.23 billion as of January 6, 2026. Its market cap has decreased by -1.66% in one year.
Market Cap
355.23B
Enterprise Value
348.29B
Revenue
49.73B
Ranking
n/a
PE Ratio
36.50
Stock Price
2,856.40
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 355.23B, an increase of 62,684.29%. That is a compound annual growth rate of 31.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 355.23B | 2.73% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.22T |
| Divi's Laboratories | 1.76T |
| Cipla | 1.24T |
| Apollo Hospitals Enterprise | 1.06T |
| Zydus Lifesciences | 936.85B |
| Mankind Pharma | 925.01B |
| Aurobindo Pharma | 715.14B |
| Fortis Healthcare | 713.44B |